P096 Limitations of fecal calprotectin at diagnosis in untreated pediatric Crohn's disease
Ron Shaoul(Rambam Health Care Campus), A. Levine, Jorge Amil Dias(Hospital de São João), G. Veerman-Wauters, Anders Pærregaard(Amager Hospital), J.C. Escher, Dan Turner(Shaare Zedek Medical Center), G. Veres, Małgorzata Sładek(Jagiellonian University), Paolo Lionetti(Meyer Children's Hospital)
Cited by 0
Related Papers
Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa
|Proceedings of the National Academy of Sciences|2010|5.6k
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
|Gastroenterology|2021|2.6k
ESPGHAN Revised Porto Criteria for the Diagnosis of Inflammatory Bowel Disease in Children and Adolescents
|Journal of Pediatric Gastroenterology and Nutrition|2013|1.4k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease
|Journal of Crohn s and Colitis|2014|1.1k